Abstract
Growth curve measurements on the EMT6 tumour following treatment with cyclophosphamide indicate a growth delay of about 3 days for each 100 mg/kg of the drug. Tumours treated whilst still microscopic show a rather longer delay for the same dose. Data for the surviving fraction of cells in the tumours measured by in vitro plating at 2 h after cyclophosphamide are not compatible with the measured growth delay and realistic values for the doubling times of surviving clonogenic cells; It is concluded that there is considerable "repair of potentially lethal damage", and that there is probably no single time after cyclophosphamide treatment at which the surviving fraction of cells can be correctly measured by the in vitro plating technique. Cell loss from cyclophosphamide-treated tumours is increased only slightly over that from untreated tumours, and the regeneration of surviving cells is very rapid. In this situation, only marginal regressions in tumour volume are caused by the highest doses of the drug.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hahn G. M., Rockwell S., Kallman R. F., Gordon L. F., Frindel E. Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation. Cancer Res. 1974 Feb;34(2):351–354. [PubMed] [Google Scholar]
- Hill R. P., Stanley J. A. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. Cancer Res. 1975 May;35(5):1147–1153. [PubMed] [Google Scholar]
- Little J. B., Hahn G. M., Frindel E., Tubiana M. Repair of potentially lethal radiation damage in vitro and in vivo. Radiology. 1973 Mar;106(3):689–694. doi: 10.1148/106.3.689. [DOI] [PubMed] [Google Scholar]
- Rockwell S. C., Kallman R. F., Fajardo L. F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst. 1972 Sep;49(3):735–749. [PubMed] [Google Scholar]
- Steel G. G., Adams K. Stem-cell survival and tumor control in the Lewis lung carcinoma. Cancer Res. 1975 Jun;35(6):1530–1535. [PubMed] [Google Scholar]
- Twentyman P. R., Bleehen N. M. Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. Br J Cancer. 1975 Oct;32(4):491–501. doi: 10.1038/bjc.1975.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Twentyman P. R., Bleehen N. M. The sensitivity to bleomycin of a solid mouse tumour at different stages of growth. Br J Cancer. 1974 Nov;30(5):469–472. doi: 10.1038/bjc.1974.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Twentyman P. R., Bleehen N. M. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. Br J Cancer. 1976 Mar;33(3):320–328. doi: 10.1038/bjc.1976.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Watson J. V. The cell proliferation kinetics of the EMT6/M/AC mouse tumour at four volumes during unperturbed growth in vivo. Cell Tissue Kinet. 1976 Mar;9(2):147–156. doi: 10.1111/j.1365-2184.1976.tb01262.x. [DOI] [PubMed] [Google Scholar]